The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Noonan syndrome and clinically related disorders
Open accessAbstract
Noonan syndrome is a relatively common, clinically variable developmental disorder. Cardinal features include postnatally reduced growth, distinctive facial dysmorphism, congenital heart defects and hypertrophic cardiomyopathy, variable cognitive deficit and skeletal, ectodermal and hematologic anomalies. Noonan syndrome is transmitted as an autosomal dominant trait, and is genetically heterogeneous. So far, heterozygous mutations in nine genes (PTPN11, SOS1, KRAS, NRAS, RAF1, BRAF, SHOC2, MEK1 and CBL) have been documented to underlie this disorder or clinically related phenotypes. Based on these recent discoveries, the diagnosis can now be confirmed molecularly in approximately 75% of affected individuals. Affected genes encode for proteins participating in the RAS-mitogen-activated protein kinases (MAPK) signal transduction pathway, which is implicated in several developmental processes controlling morphology determination, organogenesis, synaptic plasticity and growth. Here, we provide an overview of clinical aspects of this disorder and closely related conditions, the molecular mechanisms underlying pathogenesis, and major genotype-phenotype correlations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lodish, H. F. (1986) · Cited by 5,650
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
Tartaglia, M., Mehler, E. L., Goldberg, R., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,733
Self-citationNeurofibromatosis: Conference Statement
(1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290115023 · Cited by 1,547
Birth Defects: Original Article Series.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-157_8 · Cited by 1,387
The Ras superfamily at a glance
Wennerberg, K., Rossman, K. L., & Der, C. J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01660 · Cited by 1,352
Brown, A. S., Brummel‐Smith, K., Burgess, L., D'Agostino, R. B., Goldschmidt, J. W., Halter, J. B., Hazzard, W. R., Jahnigen, D. W., Phelps, C., Raskind, M., et al. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb02362.x · Cited by 1,331
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · cited 1×
“The PTPN11 gene (OMIM 176876) encodes SHP2, a cytoplasmic protein tyrosine phosphatase that positively modulate RAS signaling [72].”
BackgroundNeurofibromatosis. Conference statement, National Institute of Health development conference
Stumpf, D. A. (1988) · JAMA Neurology · Cited by 1,236
The RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,228
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Self-citationCrystal Structure of the Tyrosine Phosphatase SHP-2
Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 985
(1988) · PubMed · Cited by 817
Tartaglia, M., Kalidas, K., Shaw, A., Song, X., Musat, D. L., van der Burgt, I., Brunner, H. G., Bertola, D. R., Crosby, A., Ion, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340847 · Cited by 802
Self-citationThe RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
Tidyman, W. E., & Rauen, K. A. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.04.001 · Cited by 780
Germline KRAS mutations cause Noonan syndrome
Schubbert, S., Zenker, M., Rowe, S. L., Böll, S., Klein, C., Bollag, G., van der Burgt, I., Musante, L., Kalscheuer, V., Wehner, L.-E., et al. (2006) · Nature Genetics · doi:10.1038/ng1748 · Cited by 730
Self-citationGain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy
Pandit, B., Sarkozy, A., Pennacchio, L. A., Carta, C., Oishi, K., Martinelli, S., Pogna, E. A., Schackwitz, W., Ustaszewska, A., Landstrom, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2073 · Cited by 698
Self-citationNeurofibromatosis Type 1 Revisited
Williams, V. C., Lucas, J., Babcock, M. A., Gutmann, D. H., Korf, B., & Maria, B. L. (2009) · Pediatrics · doi:10.1542/peds.2007-3204 · Cited by 695
Germline mutations in HRAS proto-oncogene cause Costello syndrome
Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M., Kato, K., Suzuki, Y., Kure, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1641 · Cited by 679
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Roberts, A. E., Araki, T., Swanson, K. D., Montgomery, K. T., Schiripo, T. A., Joshi, V. A., Li, L., Yassin, Y., Tamburino, A. M., Neel, B. G., et al. (2007) · Nature Genetics · doi:10.1038/ng1926 · Cited by 605 · cited 3×
“SOS1—SOS1 (OMIM 182530) is the second most frequently mutated NS disease gene, accounting for approximately 10% of subjects [88-90].”
BackgroundResultGermline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloes, A., Okamoto, N., Hennekam, R. C. M., Gillessen-Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 599
Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome
Tartaglia, M., Pennacchio, L. A., Zhao, C., Yadav, K. K., Fodale, V., Sarkozy, A., Pandit, B., Oishi, K., Martinelli, S., Schackwitz, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1939 · Cited by 586
Self-citationGermline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 571
Hypertelorism With Turner Phenotype: A New Syndrome With Associated Congenital Heart Disease
Noonan, J. A. (1968) · American Journal of Diseases of Children · doi:10.1001/archpedi.1968.02100020377005 · Cited by 549
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2078 · Cited by 498
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J.-P., et al. (2007) · Nature Genetics · doi:10.1038/ng2113 · Cited by 472
Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients
Friedman, J. M., & Birch, P. H. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970516)70:2<138::aid-ajmg7>3.0.co;2-u · Cited by 432
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2004) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 427
Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 Gene
Digilio, M. C., Conti, E., Sarkozy, A., Mingarelli, R., Dottorini, T., Marino, B., Pizzuti, A., & Dallapiccola, B. (2002) · The American Journal of Human Genetics · doi:10.1086/341528 · Cited by 421
Cordeddu, V., Di Schiavi, E., Pennacchio, L. A., Ma'ayan, A., Sarkozy, A., Fodale, V., Cecchetti, S., Cardinale, A., Martin, J., Schackwitz, W., et al. (2009) · Nature Genetics · doi:10.1038/ng.425 · Cited by 419
Self-citationDiversity and functional consequences of germline and somatic PTPN11 mutations in human disease
Tartaglia, M., Martinelli, S., Stella, L., Bocchinfuso, G., Flex, E., Cordeddu, V., Zampino, G., van der Burgt, I., Palleschi, A., Petrucci, T. C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/499925 · Cited by 415
Self-citationSignaling Interplay in Ras Superfamily Function
Mitin, N., Rossman, K. L., & Der, C. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.07.010 · Cited by 399
The Cbl interactome and its functions
Schmidt, M. H. H., & Dikic, I. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1762 · Cited by 395
Niemeyer, C. M., Kang, M. W., Shin, D. H., Furlan, I., Erlacher, M., Bunin, N. J., Bunda, S., Finklestein, J. Z., Sakamoto, K. M., Gorr, T. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.641 · Cited by 374
van der Burgt, I. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-4 · Cited by 365
PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects
Kontaridis, M. I., Swanson, K. D., David, F. S., Barford, D., & Neel, B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513068200 · Cited by 338
Raf kinases: Function, regulation and role in human cancer
Leicht, D. T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., & Tzivion, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.001 · Cited by 317
A restricted spectrum of NRAS mutations causes Noonan syndrome
Cirstea, I. C., Kutsche, K., Dvorsky, R., Gremer, L., Carta, C., Horn, D., Roberts, A. E., Lepri, F., Merbitz-Zahradnik, T., König, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.497 · Cited by 315
Self-citationSarkozy, A., Carta, C., Moretti, S., Zampino, G., Digilio, M. C., Pantaleoni, F., Scioletti, A. P., Esposito, G., Cordeddu, V., Lepri, F., et al. (2009) · Human Mutation · doi:10.1002/humu.20955 · Cited by 303 · cited 5×
“In these individuals, however, polyhydramnios, HCM, and CFCS-related skin features are uncommon or absent, and cardiac defects, neurological impairment and feeding problems appear to be less severe compared to what is generally observed in CFCS [35].”
BackgroundResultInfluentialSelf-citationThe Ullrich-Noonan Syndrome (Turner Phenotype)
Nora, J. J. (1974) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1974.02110200050007 · Cited by 301
Diverse Biochemical Properties of Shp2 Mutants
Keilhack, H., David, F. S., McGregor, M., Cantley, L. C., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504699200 · Cited by 298
The Cbl family proteins: Ring leaders in regulation of cell signaling
Swaminathan, G., & Tsygankov, A. Y. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20694 · Cited by 291
Tartaglia, M. (2004) · Blood · doi:10.1182/blood-2003-11-3876 · Cited by 289
Self-citationMutations in CBL occur frequently in juvenile myelomonocytic leukemia
Loh, M. L., Sakai, D. S., Flotho, C., Kang, M., Fliegauf, M., Archambeault, S., Mullighan, C. G., Chen, L., Bergstraesser, E., Bueso-Ramos, C. E., et al. (2009) · Blood · doi:10.1182/blood-2009-01-198416 · Cited by 286
PTPN11 mutations in LEOPARD syndrome
Legius, E., Schrander-Stumpel, C., Schollen, E., Pulles-Heintzberger, C., Gewillig, M., & Fryns, J.-P. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.571 · Cited by 274
The cardiofaciocutaneous syndrome
Roberts, A., Allanson, J., Jadico, S. K., Kavamura, M. I., Noonan, J., Opitz, J. M., Young, T., & Neri, G. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.042796 · Cited by 271 · cited 1×
“Cardiofaciocutaneous syndrome and Costello syndrome—Cardiofaciocutaneous syndrome (CFCS, OMIM 115150) is a rare, sporadic multiple congenital anomalies/mental retardation syndrome characterized by failure to thrive, severe feeding problems, developmental delay, reduced growth, distinctive dysmorphic facial features, a…”
BackgroundKratz, C. P. (2005) · Blood · doi:10.1182/blood-2005-02-0531 · Cited by 267
Martinelli, S., De Luca, A., Stellacci, E., Rossi, C., Checquolo, S., Lepri, F., Caputo, V., Silvano, M., Buscherini, F., Consoli, F., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.06.015 · Cited by 259
Self-citationMarino, B., Digilio, M. C., Toscano, A., Giannotti, A., & Dallapiccola, B. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70088-0 · Cited by 258
Nava, C., Hanna, N., Michot, C., Pereira, S., Pouvreau, N., Niihori, T., Aoki, Y., Matsubara, Y., Arveiler, B., Lacombe, D., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.050450 · Cited by 256
Genotype-phenotype correlations in Noonan syndrome
Zenker, M., Buheitel, G., Rauch, R., Koenig, R., Bosse, K., Kress, W., Tietze, H.-U., Doerr, H.-G., Hofbeck, M., Singer, H., et al. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.11.032 · Cited by 249
Self-citationNoonan Syndrome: Clinical Aspects and Molecular Pathogenesis
Tartaglia, M., Zampino, G., & Gelb, B. D. (2010) · Molecular Syndromology · doi:10.1159/000276766 · Cited by 246
Self-citationNoonan syndrome: The changing phenotype
Allanson, J. E., Hall, J. G., Hughes, H. E., Preus, M., Witt, R. D., Opitz, J. M., & Reynolds, J. F. (1985) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320210313 · Cited by 239
Carta, C., Pantaleoni, F., Bocchinfuso, G., Stella, L., Vasta, I., Sarkozy, A., Digilio, C., Palleschi, A., Pizzuti, A., Grammatico, P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504394 · Cited by 225
Self-citationReynolds, J. F., Neri, G., Herrmann, J. P., Blumberg, B., Coldwell, J. G., Miles, P. V., Opitz, J. M., & Carey, J. C. (1986) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320250303 · Cited by 217
Rodriguez-Viciana, P., Oses-Prieto, J., Burlingame, A., Fried, M., & McCormick, F. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.027 · Cited by 215 · cited 7×
“NS is genetically heterogeneous, and nine genes (PTPN11, SOS1, KRAS, NRAS, RAF1, BRAF, SHOC2, MEK1 and CBL) have been causally linked to this trait or closely related conditions, including LEOPARD syndrome (LS; OMIM 151100), Noonan-like syndrome with loose anagen hair (NS/LAH, OMIM 607721), and the recently recognized…”
BackgroundInfluentialCostello syndrome: An overview
Hennekam, R. C. M. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.10019 · Cited by 213
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations
Zenker, M., Lehmann, K., Schulz, A. L., Barth, H., Hansmann, D., Koenig, R., Korinthenberg, R., Kreiss-Nachtsheim, M., Meinecke, P., Morlot, S., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.046300 · Cited by 202
Self-citationBurch, M., Sharland, M., Shinebourne, E., Smith, G., Patton, M., & McKenna, W. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90436-5 · Cited by 201
Zheng, C. F., & Guan, K. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80474-8 · Cited by 197
Voron, D. A., Hatfield, H. H., & Kalkhoff, R. K. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90764-6 · Cited by 196
A New Syndrome: Mental Subnormality and Nasal Papillomata
COSTELLO, J. M. (1977) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1977.tb01135.x · Cited by 195
Tumor predisposition in Costello syndrome
Gripp, K. W. (2005) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30065 · Cited by 193
Stops along the RAS pathway in human genetic disease
Bentires-Alj, M., Kontaridis, M. I., & Neel, B. G. (2006) · Nature Medicine · doi:10.1038/nm0306-283 · Cited by 190
Sieburth, D. S., Sun, Q., & Han, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81227-1 · Cited by 182
Binder, G., Neuer, K., Ranke, M. B., & Wittekindt, N. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0995 · Cited by 177
Noonan Syndrome: An Update and Review for the Primary Pediatrician
Noonan, J. A. (1994) · Clinical Pediatrics · doi:10.1177/000992289403300907 · Cited by 174
Smith, J. L. (1972) · Archives of Ophthalmology · doi:10.1001/archopht.1972.01000030581025 · Cited by 160
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells
Schubbert, S., Lieuw, K. H., Rowe, S. L., Lee, C. M., Li, X., Loh, M. L., Clapp, D. W., & Shannon, K. (2005) · Blood · doi:10.1182/blood-2004-11-4207 · Cited by 159
LEOPARD syndrome: Clinical diagnosis in the first year of life
Digilio, M. C., Sarkozy, A., de Zorzi, A., Pacileo, G., Limongelli, G., Mingarelli, R., Calabrò, R., Marino, B., & Dallapiccola, B. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31156 · Cited by 158
Chan, R. J., Leedy, M. B., Munugalavadla, V., Voorhorst, C. S., Li, Y., Yu, M., & Kapur, R. (2005) · Blood · doi:10.1182/blood-2004-10-4002 · Cited by 156
Niemeyer, C. M., & Kratz, C. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06958.x · Cited by 155
NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan Syndrome
Luca, A. D., Bottillo, I., Sárközy, A., Carta, C., Neri, C., Bellacchio, E., Schirinzi, A., Conti, E., Zampino, G., Battaglia, A., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/498454 · Cited by 154
Self-citationPerez, B., Mechinaud, F. M., Galambrun, C., Romdhane, N. B., Isidor, B., Philip, N., Derain-Court, J., Cassinat, B., Lachenaud, J., Kaltenbach, S., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2010.076836 · Cited by 153
Zenker, M., Horn, D., Wieczorek, D., Allanson, J. E., Pauli, S., van der Burgt, I., Doerr, H. G., Gaspar, H., Hofbeck, M., Gillessen‐Kaesbach, G., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051276 · Cited by 145
Self-citationNoonan‐like/multiple giant cell lesion syndrome
Cohen, M. M., & Gorlin, R. J. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320400208 · Cited by 129
Genotype differences in cognitive functioning in Noonan syndrome
Pierpont, E. I., Pierpont, M. E., Mendelsohn, N. J., Roberts, A. E., Tworog‐Dube, E., & Seidenberg, M. S. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00469.x · Cited by 124
Noonan phenotype associated with neurofibromatosis
Allanson, J. E., Hall, J. G., Allen, M. I. V., Opitz, J. M., & Reynolds, J. F. (1985) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320210307 · Cited by 122
Stewart, R. A., Sanda, T., Widlund, H. R., Zhu, S., Swanson, K. D., Hurley, A., Bentires‐Alj, M., Fisher, D. E., Kontaridis, M. I., Look, A. T., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.009 · Cited by 121
Reduced phosphatase activity of SHP‐2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1
Hanna, N., Montagner, A., Lee, W. H., Miteva, M. A., Vidal, M., Vidaud, M., Parfait, B., & Raynal, P. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.088 · Cited by 117
Mutation and phenotypic spectrum in patients with cardio‐facio‐cutaneous and Costello syndrome
Schulz, A., Albrecht, B., Arıcı, C., van der Burgt, I., Buske, A., Gillessen‐Kaesbach, G., Heller, R., Horn, D., Hübner, C., Korenke, G. C., et al. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00931.x · Cited by 111
Self-citationSelfors, L. M., Schutzman, J. L., Borland, C. Z., & Stern, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6903 · Cited by 111
Édouard, T., Combier, J., Nédélec, A., Bel-Vialar, S., Metrich, M., Conte-Auriol, F., Lyonnet, S., Parfait, B., Tauber, M., Salles, J., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00646-09 · Cited by 108
Narumi, Y., Aoki, Y., Niihori, T., Neri, G., Cavé, H., Verloès, A., Nava, C., Kavamura, M. I., Okamoto, N., Kurosawa, K., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31658 · Cited by 107
Improved final height with long-term growth hormone treatment in Noonan syndrome
Osio, D., Dahlgren, J., Wikland, K. A., & Westphal, O. (2005) · Acta Paediatrica · doi:10.1080/08035250510031476 · Cited by 107
Biochemical and Functional Characterization of Germ Line KRAS Mutations
Schubbert, S., Bollag, G. E., Lyubynska, N., Nguyen, H. T., Kratz, C. P., Zenker, M., Niemeyer, C. M., Molven, A., & Shannon, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00965-07 · Cited by 103
Self-citationOishi, K., Zhang, H., Gault, W. J., Wang, C. J., Tan, C. C., Kim, I.-K., Ying, H., Rahman, T., Pica, N., Tartaglia, M., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn336 · Cited by 103
Self-citationMartinelli, S., Torreri, P., Tinti, M., Stella, L., Bocchinfuso, G., Flex, E., Grottesi, A., Ceccarini, M., Palleschi, A., Cesareni, G., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn099 · Cited by 100
Self-citationAllanson, J. E. (2007) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30138 · Cited by 99
Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade
Cesarini, L., Alfieri, P., Pantaleoni, F., Vasta, I., Cerutti, M., Petrangeli, V., Mariotti, P., Leoni, C., Ricci, D., Vicari, S., et al. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32488 · Cited by 98 · cited 1×
“Available data indicate that the heterogeneity in cognitive abilities observed in NS is at least partially ascribed to the specifics of the causative gene mutation [21,22].”
BackgroundSelf-citationA comprehensive scoring system for evaluating noonan syndrome
Duncan, W. J., Fowler, R. S., Farkas, L. G., Ross, R. B., Wright, A. W., Bloom, K. R., Huot, D., Sondheimer, H. M., Rowe, R. D., & Opitz, J. M. (1981) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320100106 · Cited by 98
Growth hormone treatment in Noonan syndrome: The National Cooperative Growth Study experience
Romano, A. A., Blethen, S. L., b, K. D., et al. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70005-7 · Cited by 97
Noordam, C., Peer, P. G. M., François, I., Schepper, J. D., Burgt, I. V. D., & Otten, B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0413 · Cited by 97
Noonan and cardio-facio-cutaneous syndromes: two clinically and genetically overlapping disorders
Nyström, A., Ekvall, S., Berglund, E., Björkqvist, M., Braathen, G. J., Duchén, K., Enell, H., Holmberg, E., Holmlund, U., Olsson‐Engman, M., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057653 · Cited by 96
Nimnual, A. S., & Bar‐Sagi, D. (2002) · Science Signaling · doi:10.1126/stke.2002.145.pe36 · Cited by 90
The leopard (multiple lentigines) syndrome revisited
Gorlin, R. J., Anderson, R. C., & Moller, J. H. (1971) · The Laryngoscope · doi:10.1288/00005537-197110000-00015 · Cited by 89
Somatic PTPN11 mutations in childhood acute myeloid leukaemia
Tartaglia, M., Martinelli, S., Iavarone, I., Cazzaniga, G., Spinelli, M., Giarin, E., Petrangeli, V., Carta, C., Masetti, R., Aricò, M., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05457.x · Cited by 88
Self-citationDentici, M. L., Sárközy, A., Pantaleoni, F., Carta, C., Lepri, F. R., Ferese, R., Cordeddu, V., Martinelli, S., Briuglia, S., Digilio, M. C., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.256 · Cited by 85
Self-citationShort stature in Noonan syndrome: response to growth hormone therapy
Kirk, J. M. W. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.84.5.440 · Cited by 85
Adult height in Noonan syndrome
Noonan, J. A., Raaijmakers, R., & Hall, B. D. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20502 · Cited by 82
Bertola, D. R., Pereira, A. C., Passetti, F., de Oliveira, P. S. L., Messiaen, L. M., Gelb, B. D., Kim, C. A., & Krieger, J. E. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30813 · Cited by 81
Self-citationMultiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome
Neumann, T. E., Allanson, J. E., Kavamura, M. I., Kerr, B. A., Neri, G., Noonan, J. A., Cordeddu, V., Gibson, K., Tzschach, A., Krüger, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.188 · Cited by 79
Self-citationPhenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome
Lee, J. S., Tartaglia, M., Gelb, B. D., Fridrich, K., Sachs, S., Stratakis, C. A., Muenke, M., Robey, P. G., Collins, M. T., & Slavotinek, A. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024091 · Cited by 75
Self-citationDifferent mutations in theNF1gene are associated with Neurofibromatosis–Noonan syndrome (NFNS)
Baralle, D., Mattocks, C., Kalidas, K., Elmslie, F., Whittaker, J., Lees, M. M., Ragge, N., Patton, M. A., Winter, R. M., & ffrench‐Constant, C. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20023 · Cited by 71
Feeding difficulties and foregut dysmotility in Noonan's syndrome
Shah, N., Rodriguez, M., Louis, D., et al. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.81.1.28 · Cited by 68
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations
Kratz, C. P., Zampino, G., Kriek, M., Kant, S. G., Leoni, C., Pantaleoni, F., Oudesluys‐Murphy, A. M., Rocco, C. D., Kloska, S. P., Tartaglia, M., et al. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32786 · Cited by 62
Self-citationIndependent NF1 and PTPN11 mutations in a family with neurofibromatosis‐Noonan syndrome
Thiel, C. T., Wilken, M., Zenker, M., Sticht, H., Fahsold, R., Gusek-Schneider, G.-C., & Rauch, A. M. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32837 · Cited by 62
Self-citationThe Leopard (multiple lentigines) syndrome revisited.
Rj, G., Rc, A., & Jh, M. (1971) · PubMed · Cited by 59
Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence
Koudová, M., Seemanová, E., & Zenker, M. (2009) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2009.04.006 · Cited by 57
Self-citationHüffmeier, U., Zenker, M., Hoyer, J., Fahsold, R., & Rauch, A. M. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31547 · Cited by 55
Self-citationSOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions
Bénéteau, C., Cavé, H., Moncla, A., Dorison, N., Münnich, A., Verloès, A., & Leheup, B. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.44 · Cited by 54
Noonan syndrome and related disorders
Noonan, J. A. (2005) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2005.04.008 · Cited by 52
Neurofibromatosis-Noonan syndrome
Carey, J. C. (1998) · American Journal of Medical Genetics · Cited by 43
Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1
Nyström, A., Ekvall, S., Allanson, J. E., Edeby, C., Elinder, M., Holmström, G., Bondeson, M.-L., & Annerén, G. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01233.x · Cited by 40
Noordam, C., van der Burgt, I., Sengers, R. C. A., de Waal, H. A. D., & Otten, B. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb02452.x · Cited by 35
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Pierpont, M. E., Brueckner, M., Chung, W. K., Garg, V., Lacro, R. V., McGuire, A. L., Mital, S., Priest, J. R., Pu, W. T., Roberts, A., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000606 · Cited by 654
Self-citationMolecular genetic testing and the future of clinical genomics
Katsanis, S. H., & Katsanis, N. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3493 · Cited by 425
The neural crest in cardiac congenital anomalies
Keyte, A., & Hutson, M. R. (2012) · Differentiation · doi:10.1016/j.diff.2012.04.005 · Cited by 259
SHP2 sails from physiology to pathology
Tajan, M., de Rocca Serra, A., Valet, P., Edouard, T., & Yart, A. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.08.005 · Cited by 232
Metadata
- Authors
- Tartaglia, M., Gelb, B. D., & Zenker, M.
- Venue
- Best Practice & Research Clinical Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 25
- Issue
- 1
- Pages
- 161-179
- ISSN
- 1521-690X (ISSN-L)
- OpenAlex
- W2081635903
- Cited by
- 414
- References
- 114
- FWCI
- 10.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.